Transcontinental Translational Medicine Collaboration: A Successful SinoCuban Joint B-to-B Program

作     者：LU Kai CHEN Tao CHEN Yu George F. Gao 

作者机构：Chinese Center for Disease Control and Prevention 

出 版 物：《Biomedical and Environmental Sciences》 (生物医学与环境科学（英文版）)

年 卷 期：2013年第26卷第7期

页      面：517-519页

核心收录：

学科分类：10[医学] 

主　　题：Transcontinental Translational Medicine Collaboration A Successful SinoCuban Joint B-to-B Program 

摘      要：Translational medicine is a comprehensive discipline that aims to convert laboratory research results into products and technology for clinical application using modern molecular biological techniques, to improve our understanding of the human body and disease and to optimize laboratory design for clinical observation and analysis for basic research. Its ultimate goal is improving holistic medicine and helping patients solve their health problems. Translational medicine includes two processes： bench to bedside and bedside to bench, known as B-to-B processes. The first B-to-B （bench to bedside） refers to the application of results of the laboratory to clinical use as a medical product or a diagnosis and treatment technology. The second B-to-B （bedside to bench） describes the process by which clinical observation and analysis provides ideas and guidance for experiment design for basic medical research. The two processes complement each other and constitute the two-way cycle of translational medicine. Translational medicine can be applied to clinical disease detection in the form of new biomarkers and can accelerate drug discovery. In recent years, with the biotechnology, increasing rapid development of outcomes of research on molecular pathogenesis can be directly applied to clinical theraDv.